These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The separation and characterization of marmoset kidney beta-D-galactosidase and beta-D-glucosidase. Pierce RJ; Price RG Biochem J; 1977 Dec; 167(3):765-73. PubMed ID: 23762 [TBL] [Abstract][Full Text] [Related]
26. Role of Nanotechnology for Enzyme Replacement Therapy in Lysosomal Diseases. A Focus on Gaucher's Disease. Martín-Banderas L; Holgado MA; Durán-Lobato M; Infante JJ; Álvarez-Fuentes J; Fernández-Arévalo M Curr Med Chem; 2016; 23(9):929-52. PubMed ID: 26860997 [TBL] [Abstract][Full Text] [Related]
27. Enzyme replacement therapy for the sphingolipidoses. Brady RO; Pentchev PG; Gal AE; Hibbert SR; Quirk JM; Mook GE; Kusiak JW; Tallman JF; Dekaban AS Adv Exp Med Biol; 1976; 68():523-32. PubMed ID: 820173 [No Abstract] [Full Text] [Related]
28. An appraisal of human trials in enzyme replacement therapy of genetic diseases. Tager JM; Hamers MN; Schram AW; Van den Bergh FA; Rietra PJ; Loonen C; Koster JF; Slee R Birth Defects Orig Artic Ser; 1980; 16(1):343-59. PubMed ID: 6778527 [No Abstract] [Full Text] [Related]
29. On the separation of old from young erythrocytes in hypotonic bovine serum albumin solutions. Danon D; Marikovsky Y; Furedi A; Ohad I Biochim Biophys Acta; 1965 Jun; 104(1):281-4. PubMed ID: 5840405 [No Abstract] [Full Text] [Related]
30. Enzyme therapy XIV. Comparison of methods for enzyme entrapment in human erythrocytes. Fiddler MB; Hudson LD; White JG; Desnick RJ J Lab Clin Med; 1980 Aug; 96(2):307-17. PubMed ID: 7400665 [TBL] [Abstract][Full Text] [Related]
31. The cellular distribution of some rat-kidney glycosidases. Price RG; Dance N Biochem J; 1967 Nov; 105(2):877-83. PubMed ID: 5584024 [TBL] [Abstract][Full Text] [Related]
32. Developmental changes of glycosidase activities in rat renal cortex. Schulze E; Böhme HJ; Hofmann E Biomed Biochim Acta; 1986; 45(5):601-9. PubMed ID: 3019325 [TBL] [Abstract][Full Text] [Related]
34. Enzyme replacement with red cells. N Engl J Med; 1977 Apr; 296(16):942-3. PubMed ID: 846521 [No Abstract] [Full Text] [Related]
35. Erythrocyte membranes from slaughterhouse blood as potential drug vehicles: Isolation by gradual hypotonic hemolysis and biochemical and morphological characterization. Kostić IT; Ilić VL; Đorđević VB; Bukara KM; Mojsilović SB; Nedović VA; Bugarski DS; Veljović ĐN; Mišić DM; Bugarski BM Colloids Surf B Biointerfaces; 2014 Oct; 122():250-259. PubMed ID: 25051307 [TBL] [Abstract][Full Text] [Related]
36. Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. Gregoriadis G; Ryman BE Biochem J; 1971 Oct; 124(5):58P. PubMed ID: 5130994 [No Abstract] [Full Text] [Related]
39. Structural basis for enzyme bifunctionality - the case of Gan1D from Geobacillus stearothermophilus. Lansky S; Zehavi A; Belrhali H; Shoham Y; Shoham G FEBS J; 2017 Nov; 284(22):3931-3953. PubMed ID: 28975708 [TBL] [Abstract][Full Text] [Related]
40. Human erythrocytes as drug carriers: loading efficiency and side effects of hypotonic dialysis, chlorpromazine treatment and fusion with liposomes. Favretto ME; Cluitmans JC; Bosman GJ; Brock R J Control Release; 2013 Sep; 170(3):343-51. PubMed ID: 23747798 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]